Risk Factors for Recurrence of Clostridium difficile Infection: Effect of Vancomycin-resistant Enterococci Colonization

被引:35
作者
Choi, Hee Kyoung [1 ]
Kim, Kye Hyung [1 ]
Lee, Sun Hee [1 ]
Lee, Su Jin [1 ]
机构
[1] Pusan Natl Univ, Sch Med, Med Res Inst, Dept Internal Med,Div Infect Dis, Pusan, South Korea
关键词
Clostridium difficile; Recurrence; Risk factors; VRE; ORAL METRONIDAZOLE; DIARRHEA; DISEASE; EPIDEMIOLOGY; CONTAMINATION; PROTECTION; OUTBREAK; COLITIS; FAECIUM;
D O I
10.3346/jkms.2011.26.7.859
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recurrent Clostridium difficile infection (CDI) is one of the most difficult problems in healthcare infection control. We evaluated the risk factors associated with recurrence in patients with CDI. A retrospective cohort study of 84 patients with CDI from December 2008 through October 2010 was performed at Pusan National University Yangsan Hospital. Recurrence occurred in 13.1% (11/84) of the cases and in-hospital mortality rate was 7.1% (6/84). Stool colonization with vancomycin-resistant enterococci (VRE) (P = 0.006), exposure to more than 3 antibiotics (P = 0.009), low hemoglobin levels (P = 0.025) and continued use of previous antibiotics (P = 0.05) were found to be more frequent in the recurrent group. Multivariate analysis indicated that, stool VRE colonization was independently associated with CDI recurrence (odds ratio, 14.519; 95% confidence interval, 1.157-182.229; P = 0.038). This result suggests that stool VRE colonization is a significant risk factor for CDI recurrence.
引用
收藏
页码:859 / 864
页数:6
相关论文
共 30 条
[21]  
Lee Yune Jeong, 2010, Korean J Gastroenterol, V55, P169
[22]   In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E-faecium isolate of human origin in the intestines of human volunteers [J].
Lester, CH ;
Frimodt-Moller, N ;
Sorensen, TL ;
Monnet, DL ;
Hammerum, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :596-599
[23]   Recurrent Clostridium difficile [J].
Maroo, S ;
Lamont, JT .
GASTROENTEROLOGY, 2006, 130 (04) :1311-1316
[24]   Recurrent Clostridium difficile disease:: Epidemiology and clinical characteristics [J].
McFarland, LV ;
Surawicz, CM ;
Rubin, M ;
Fekety, R ;
Elmer, GW ;
Greenberg, RN .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (01) :43-50
[25]   Lack of Increased Colonization with Vancomycin-Resistant Enterococci during Preferential Use of Vancomycin for Treatment during an Outbreak of Healthcare-Associated Clostridium difficile Infection [J].
Miller, Mark ;
Bernard, Lisa ;
Thompson, Melissa ;
Grima, Daniel ;
Pepin, Jocelyne .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (07) :710-715
[26]   Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada [J].
Pépin, J ;
Alary, ME ;
Valiquette, L ;
Raiche, E ;
Ruel, J ;
Fulop, K ;
Godin, D ;
Bourassa, C .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) :1591-1597
[27]   Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile [J].
Salgado, CD ;
Giannetta, ET ;
Farr, BM .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (05) :413-417
[28]   Skin and Environmental Contamination With Vancomycin-Resistant Enterococci in Patients Receiving Oral Metronidazole or Oral Vancomycin Treatment for Clostridium difficile-Associated Disease [J].
Sethi, Ajay K. ;
Al-Nassir, Wafa N. ;
Nerandzic, Michelle M. ;
Donskey, Curtis J. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (01) :13-17
[29]   The First Case of Antibiotic-associated Colitis by Clostridium difficile PCR Ribotype 027 in Korea [J].
Tae, Chung Hyun ;
Jung, Sung-Ae ;
Song, Hyun Joo ;
Kim, Seong-Eun ;
Choi, Hee Jung ;
Lee, Miae ;
Hwang, Yusun ;
Kim, Heejung ;
Lee, Kyungwon .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (03) :520-524
[30]   Risk factors for recurrence of Clostridium difficile-associated diarrhea in the elderly [J].
Tal, S ;
Gurevich, A ;
Guller, V ;
Gurevich, I ;
Berger, D ;
Levi, S .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2002, 34 (08) :594-597